⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | JM Mid Cap Fund - Growth - Direct Plan | Kotak Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | Kotak MF |
| Category | Equity - Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹21.94 (06 Nov 2026) | ₹18.07 (06 Nov 2026) |
| Rating | ★★★★★ | ★★★ |
| Benchmark | Nifty Midcap 150 - TRI | Nifty Healthcare Index - TRI |
| Fund Manager | Satish Ramanathan | Dhananjay Tikariha |
| Inception | 21 Nov 2022 | 11 Dec 2023 |
| Returns | ||
| 1Y | 7.51% | 27.15% |
| 3Y | 18.88% | — |
| 5Y | — | — |
| Since Inception | 22.16% | 22.57% |
| Risk | ||
| 17.12 | 14.88 | |
| 0.97 | 0.99 | |
| 0.69 | 1.02 | |
| 3.68 | 3.82 | |
| 1.39 | 2.12 | |
| -11.75% | -11.03% | |
| Costs | ||
| Expense Ratio | 0.95% | 1.03% |
| Exit Load | 1% on or before 180D, Nil after 180D | 0.50% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
JM Mid Cap Fu…95%
Kotak MF95%
5.0%Only 5.0% of holdings by weight are common between JM Mid Cap Fund - Growth - Direct Plan and Kotak MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingJM Mid Cap Fund - Growth - Direct PlanKotak MF
Mankind Pharma Ltd.2.89%2.73%
Acutaas Chemicals Ltd.2.28%4.17%
Category context: Equity vs Equity. Open the full Screener →